期刊文献+

原发性输尿管癌的诊断与治疗(附21例报告) 被引量:4

Diagnosis and treatment of primary ureteral cancer(report of 21 cases)
下载PDF
导出
摘要 目的加强对原发性输尿管癌的认识,提高对原发性输尿管癌的诊断及治疗水平。方法回顾性分析21例输尿管癌患者的临床资料,比较术前彩超、泌尿系CT成像(CTurography,CTU)和输尿管镜检等诊断符合率情况,讨论术前检查方法的差异。所有患者均行手术治疗,术后常规行膀胱灌注治疗,评估治疗后情况,总结原发性输尿管癌的诊断及治疗经验。结果所有患者的术后病检结果均为输尿管癌。比较术前彩超、CTU和输尿管镜检等检查结果表明,CTU和输尿管镜检诊断符合率明显高于彩超,差异具有统计学意义(P<0.05),CTU和输尿管镜检对输尿管癌的诊断符合率均较高,两者间差异无统计学意义(P>0.05)。A、B期输尿管癌患者尽早手术,术后获得较好的预后。结论对于输尿管肿瘤患者,应联合进行CTU和输尿管镜检查,早发现、早治疗,尽可能采取肾、输尿管全长及膀胱袖状切除术,条件许可时,可采用组合腔镜技术。术后规律随访并膀胱灌注腔内化疗,有利于预防输尿管癌术后膀胱癌复发,改善输尿管癌的预后。 Objective To strengthen the theory about primary ureteral carcinoma and elevate diagnosis and treatment of primary ureteral cancer. Methods We reviewed data of 21 patients of primary ureteral cancer, and campared the result of color ultrasonography, CTU, ureteroscopy and pathological diagnosis and evaluated various kinds of diagnostic means. All patients accepted opera- tions (either open or laparoseopic radical nephroureterectomy) and bladder intracavitary chemothera py post operation. We summarized the diagnostic and therapeutic experience. Results The diagnosis was confirmed by pathology. Campared with color ultrasonography, CTU and ureteroscopy vcere much more accurate (P^0.05). There was no difference between CTU and ureteroscopy (P〉0.05). Patients treated with radical nephroureterectomy got a better outcome especially as theywere early stage (stage A and/or stage B). Conclusions We should take more attention to the patients who maybe suffer from the primary ureteral tumor. Examination (CTU and/or ureteroscopy) should be performed. Treatment should be clone as diagnosis confirmed. Radical nephroureterectomy is the first choice for patients. Postoperative follow-up and bladder intracavitary chemotherapy regularly are the key points to improve the tumor-free survival time of patients.
出处 《现代泌尿生殖肿瘤杂志》 2012年第3期135-137,共3页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 原发性输尿管癌 输尿管镜检查 诊断 治疗 Primary ureteral cancer Ureteroscopyl Diagnosis Therapy
  • 相关文献

参考文献10

  • 1Oosterlinck W, Solsona E, van der Meijden AP, et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma[J]. Eur Urol, 2004,46 (2) : 147- 154. 被引量:1
  • 2周惜才,陈园.原发性输尿管癌诊疗进展[J].现代泌尿生殖肿瘤杂志,2010,2(2):65-68. 被引量:4
  • 3张骞,王秉东,王杰平,赵亚元,孙晓伟,郝金瑞,何志嵩.影像学检查诊断上尿路移行细胞癌的比较及临床意义(附234例分析)[J].北京大学学报(医学版),2009,41(6):687-690. 被引量:10
  • 4Xu AD, Ng CS, Kamat A, et al. Significance of upper urina ry tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms[J]. AmJ Roentgenol,2010,195(4):959-965. 被引量:1
  • 5Ito Y, Kikuchi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in pa- tients undergoing nephroureterectomy for upper tract urothelial earcinoma[J]. J Urol,2011,185(5) :1621-1626. 被引量:1
  • 6Lim DJ, Shattuck MC, Cook WA. Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ure- terorenoscopy[J]. J Uro1,1993,149(1) :109-111. 被引量:1
  • 7徐鑫,张冠.输尿管镜探查术后输尿管癌进展2例报告[J].现代泌尿生殖肿瘤杂志,2009,1(2):108-109. 被引量:8
  • 8Ishikawa S, Abe T, ShinoharaN, et al. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in pa- tients with urothelial carcinoma of the upper urinary tract[J]. J Urol,2010,184(3):883-887. 被引量:1
  • 9Walton TJ, Novara G, Matsumoto K, et al. Oncological out- comes after laparoscopic and open radical nephroureterecto- my: results from an international cohort[J]. BJU Int,2011, 108(3) :406-412. 被引量:1
  • 10Azemar MD, Comperat E, Richard F, et al. Bladder recur- rence after surgery for upper urinary tract urothelial cell car cinoma: frequency, risk factors, and surveillance[J]. Urol Oncol,2011,29(2): 130-136. 被引量:1

二级参考文献40

共引文献18

同被引文献36

  • 1潘柏年,张争,刘玉立,郭应禄.174例原发性输尿管癌的临床分析[J].中华外科杂志,2004,42(23):1447-1449. 被引量:59
  • 2陈晓荣,余建群,王宏宇,周翔平,杨志刚,杨瑞,毛芸.MRU联合常规MRI对输尿管病变的诊断价值[J].四川大学学报(医学版),2006,37(4):656-658. 被引量:8
  • 3邱乾德,郭献日,许加俊,刘绪明,吴海.原发性输尿管移行上皮细胞癌的MR诊断[J].中华放射学杂志,2006,40(10):1082-1085. 被引量:7
  • 4那彦群,叶章群,孙光,等.中国泌尿外科疾病诊断治疗指南[M].人民卫生出版社,2011:30. 被引量:6
  • 5Milojevic B, Djokic M, Sipetic - Grujicic S, et al. Bladder cancer after managing upper uri- nary tract transitional cell carcinoma: risk fac- tors and survival [ J ]. Int Urol Nephrol, 2011, 43 (3): 729 -735. 被引量:1
  • 6Favaretto RL, Shariat SF, Chade DC, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at me- morial sloan - kettefing cancer center [ J ]. Eur Uml, 2010, 58 (4): 574-580. 被引量:1
  • 7Hermanova M, Vitezslav V, Husicka R, et 81. Multicentric transitional cell carcinoma of the vagina and the ureter [ J ]. Ann Diagn Pathol, 2008, 12 (5) : 365 -367. 被引量:1
  • 8Xu AD, Ng CS, Kamat A, et al. Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms [J]. Am J Roentge.ol, 2010, 195(4):959-965. 被引量:1
  • 9Ito Y, Kikuehi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma [J]. J Urol., 2011, 185(5):1621-1626. 被引量:1
  • 10Luo B, Li W, Deng CH. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma [J]. Cancer Genet Cytogenet, 2009, 189(2):93-97. 被引量:1

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部